Atorvastatin and prostate cancer - a phase 2 clinical trial

被引：0
|
作者：
Murtola, Teemu J.
Riikonen, Jarno
Syvala, Heimo
Tolonen, Teemu
Koskimaki, Juha
Pakarainen, Tomi
Kaipia, Antti
Isotalo, Taina
Kujala, Paula
Tammela, Teuvo
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-CT133
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT133
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Phase II Trial of Carboplatin, Everolimus, and Prednisone in Metastatic Castration-resistant Prostate Cancer Pretreated With Docetaxel Chemotherapy: A Prostate Cancer Clinical Trial Consortium Study
    Vaishampayan, Ulka
    Shevrin, Daniel
    Stein, Mark
    Heilbrun, Lance
    Land, Susan
    Stark, Karri
    Li, Jing
    Dickow, Brenda
    Heath, Elisabeth
    Smith, Daryn
    Fontana, Joseph
    UROLOGY, 2015, 86 (06) : 1206 - 1211
  • [32] Prostate cancer clinical trial completion: The role of geography
    Stensland, Kristian D.
    Kaffenberger, Samuel D.
    George, Arvin K.
    Morgan, Todd M.
    Miller, David C.
    Salami, Simpa S.
    Dunn, Rodney L.
    Palapattu, Ganesh S.
    Montgomery, Jeffrey S.
    Hollenbeck, Brent K.
    Skolarus, Ted A.
    CONTEMPORARY CLINICAL TRIALS, 2021, 111
  • [33] Clinical Trial Enrollment in a Multidisciplinary Prostate Cancer Clinic
    Domain, D.
    Hoffman, K. E.
    Madsen, L. T.
    Pettaway, C. A.
    Kim, J.
    Davis, J. W.
    Lee, A. K.
    Pisters, L.
    Levy, L.
    Kuban, D. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S555 - S555
  • [34] Ongoing Clinical Trials in Prostate Cancer: The STAMPEDE Trial
    Oing, Christoph
    Bokemeyer, Carsten
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (7-8) : 464 - 467
  • [35] Re: Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial
    Augugliaro, Matteo
    Pepa, Matteo
    Marvaso, Giulia
    Jereczek-Fossa, Barbara Alicja
    EUROPEAN UROLOGY, 2021, 79 (06) : 889 - +
  • [36] Phase 2 clinical trial of TORC1 inhibition with everolimus in men with metastatic castration-resistant prostate cancer
    George, Daniel J.
    Halabi, Susan
    Healy, Patrick
    Jonasch, Darius
    Anand, Monika
    Rasmussen, Julia
    Wood, Sarah Y.
    Spritzer, Charles
    Madden, John F.
    Armstrong, Andrew J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (03) : 79.e15 - 79.e22
  • [37] Phase I clinical trial of a PSA, IL-2, GM-CSF containing prostate cancer vaccine in PSA defined biochemical recurrent prostate cancer patients
    Head, Jonathan F.
    Daniels, Gregory A.
    McKinney, Michelle
    Ongkeko, Weg
    Sakamoto, Kyoko
    Wang-Rodriguez, Jessica
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
  • [38] Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial
    Eugene Shenderov
    Angelo M. De Marzo
    Tamara L. Lotan
    Hao Wang
    Sin Chan
    Su Jin Lim
    Hongkai Ji
    Mohamad E. Allaf
    Carolyn Chapman
    Paul A. Moore
    Francine Chen
    Kristina Sorg
    Andrew M. White
    Sarah E. Church
    Briana Hudson
    Paul A. Fields
    Shaohui Hu
    Samuel R. Denmeade
    Kenneth J. Pienta
    Christian P. Pavlovich
    Ashley E. Ross
    Charles G. Drake
    Drew M. Pardoll
    Emmanuel S. Antonarakis
    Nature Medicine, 2023, 29 : 888 - 897
  • [39] Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial
    Shenderov, Eugene
    De Marzo, Angelo M. M.
    Lotan, Tamara L. L.
    Wang, Hao
    Chan, Sin
    Lim, Su Jin
    Ji, Hongkai
    Allaf, Mohamad E. E.
    Chapman, Carolyn
    Moore, Paul A. A.
    Chen, Francine
    Sorg, Kristina
    White, Andrew M. M.
    Church, Sarah E. E.
    Hudson, Briana
    Fields, Paul A. A.
    Hu, Shaohui
    Denmeade, Samuel R. R.
    Pienta, Kenneth J. J.
    Pavlovich, Christian P. P.
    Ross, Ashley E. E.
    Drake, Charles G. G.
    Pardoll, Drew M. M.
    Antonarakis, Emmanuel S. S.
    NATURE MEDICINE, 2023, 29 (4) : 888 - 897
  • [40] Salvage radiotherapy in oligorecurrent pelvic node relapses of prostate cancer : a phase 2 trial
    Supiot, S.
    Pasquier, D.
    Buthaud, X.
    Magne, N.
    Becckendorf, V.
    Crehange, G.
    Pommier, P.
    Loos, G.
    Hasbini, A.
    Latorzeff, I.
    Silva, M.
    Denis, F.
    Campion, L.
    Vaugier, L.
    Blanc-Lapierre, A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S105 - S105
12345